Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K
26 avr. 2023 12h15 HE
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...
Aridis Provides Corporate Update
31 mars 2023 19h00 HE
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on...
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
25 janv. 2023 16h05 HE
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results from the AR-301-002 Phase 3 study, which evaluated the superiority of...
HAP President and CEO Andy Carter to Retire
18 nov. 2022 10h05 HE
|
The Hospital and Healthsystem Association of Pennsylvania
Harrisburg, PA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Andy Carter, president and CEO of The Hospital and Healthsystem Association of Pennsylvania (HAP) since 2012, today announced his plan to retire by...
Pa. Hospitals Recognized for Innovative COVID Response
31 mars 2022 10h24 HE
|
The Hospital and Healthsystem Association of Pennsylvania
Harrisburg, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- The Hospital and Healthsystem Association of Pennsylvania (HAP) is recognizing four Pennsylvania health care teams for their exemplary projects...
HAP Announces 2020 Achievement Awards Winners
10 août 2020 11h15 HE
|
The Hospital and Healthsystem Association of Pennsylvania
Harrisburg, PA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Pennsylvania is home to a diverse hospital community, whose leadership and staff are focused on weaving the needs of their patients into every facet...